Sequencing-based analytics offer potential for rapid sterility and adventitious agent testing

This presentation explores our work in leveraging next-generation sequencing (NGS) for rapid analytics. Our approach can streamline traditional sterility and viral testing – reducing turnaround times while enabling more sensitive detection of potential contaminants, and represents a key step towards faster, more comprehensive quality insights for cell therapy product development.